102 related articles for article (PubMed ID: 8614366)
1. Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography.
Lang P; Vahlensieck M; Matthay KK; Johnston JO; Rosenau W; Gooding CA; Genant HK
Med Pediatr Oncol; 1996 May; 26(5):329-33. PubMed ID: 8614366
[TBL] [Abstract][Full Text] [Related]
2. Primary bone tumors: value of MR angiography for preoperative planning and monitoring response to chemotherapy.
Lang P; Grampp S; Vahlensieck M; Johnston JO; Honda G; Rosenau W; Matthay KK; Peterfy C; Higgins CB; Genant HK
AJR Am J Roentgenol; 1995 Jul; 165(1):135-42. PubMed ID: 7785572
[TBL] [Abstract][Full Text] [Related]
3. [Potentialities of MR tomography in monitoring the therapy of malignant bone tumors].
Just M; Gutjahr P; Higer HP; Störkel S; Rudigier J; Ritter G; Pfannenstiel P
Rofo; 1987 Oct; 147(4):413-9. PubMed ID: 2825264
[TBL] [Abstract][Full Text] [Related]
4. The potential of MRI in preoperative evaluation of chemotherapy-induced necrosis in osteosarcoma and Ewing's sarcoma.
Maas R; Winkler K; Delling G; Heise U
Chir Organi Mov; 1990; 75(1 Suppl):41-4. PubMed ID: 2249554
[No Abstract] [Full Text] [Related]
5. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC
AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
[TBL] [Abstract][Full Text] [Related]
6. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.
Fletcher BD; Hanna SL; Fairclough DL; Gronemeyer SA
Radiology; 1992 Jul; 184(1):243-8. PubMed ID: 1319075
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted imaging as predictor of therapy response in an animal model of Ewing sarcoma.
Reichardt W; Juettner E; Uhl M; Elverfeldt DV; Kontny U
Invest Radiol; 2009 May; 44(5):298-303. PubMed ID: 19346963
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
9. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
[TBL] [Abstract][Full Text] [Related]
10. [Malignant bone tumours in children and adolescent].
Bollini G; Kalifa C; Panuel M
Arch Pediatr; 2006 Jun; 13(6):669-71. PubMed ID: 16697603
[No Abstract] [Full Text] [Related]
11. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH
Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.
Bond M; Bernstein ML; Pappo A; Schultz KR; Krailo M; Blaney SM; Adamson PC
Pediatr Blood Cancer; 2008 Feb; 50(2):254-8. PubMed ID: 17262795
[TBL] [Abstract][Full Text] [Related]
13. [Osteosarcoma: magnetic resonance imaging of the effects of preoperative chemotherapy].
Spina V; Torricelli P; Manfrini M; Picci P; Romagnoli R
Radiol Med; 1993 Jun; 85(6):725-32. PubMed ID: 8337428
[TBL] [Abstract][Full Text] [Related]
14. Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: implication for cell-based therapy in bone defect reconstruction.
Beccheroni A; Lucarelli E; Donati D; Sangiorgi L; Capponcelli S; Gorini M; Zambon Bertoja A; Giardino R; Mercuri M; Ferrari S; Bacci G; Picci P
Oncol Rep; 2003; 10(4):891-6. PubMed ID: 12792741
[TBL] [Abstract][Full Text] [Related]
15. Ewing's sarcoma of the middle finger in an infant.
Saitoh S; Hatori M; Ehara S; Kokubun S
Orthopedics; 2000 Apr; 23(4):379-80. PubMed ID: 10791588
[No Abstract] [Full Text] [Related]
16. [The role of polychemotherapy in the management of malignant bone tumors].
Reichardt P; Dörken B
Chirurg; 2002 Dec; 73(12):1170-3. PubMed ID: 12491045
[TBL] [Abstract][Full Text] [Related]
17. [Ewing's sarcoma in children--current surgical treatment options, evaluation of our patients].
Schovanec J; Mrácek J; Havlas V; Trc T
Acta Chir Orthop Traumatol Cech; 2004; 71(4):220-7. PubMed ID: 15456100
[TBL] [Abstract][Full Text] [Related]
18. [Osteosarcoma and Ewing's sarcoma. Improved recovery chances in the past 25 years according to the experience of Balgrist Hospital].
Exner GU; von Hochstetter AR; Schreiber A; Sokolovic-Dalipagic E
Praxis (Bern 1994); 1996 May; 85(22):706-13. PubMed ID: 8693235
[TBL] [Abstract][Full Text] [Related]
19. [Preoperative adjuvant therapy for primary malignant bone tumors].
Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
[TBL] [Abstract][Full Text] [Related]
20. Epiphyseal primary location for osteosarcoma and Ewing sarcoma in patients with open physis.
Muscolo DL; Campaner G; Aponte-Tinao LA; Ayerza MA; Santini-Araujo E
J Pediatr Orthop; 2003; 23(4):542-5. PubMed ID: 12826957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
